ATE460422T1 - Herstellung von flumethasone und dessen 17- carboxyl androsten analog - Google Patents

Herstellung von flumethasone und dessen 17- carboxyl androsten analog

Info

Publication number
ATE460422T1
ATE460422T1 AT02735607T AT02735607T ATE460422T1 AT E460422 T1 ATE460422 T1 AT E460422T1 AT 02735607 T AT02735607 T AT 02735607T AT 02735607 T AT02735607 T AT 02735607T AT E460422 T1 ATE460422 T1 AT E460422T1
Authority
AT
Austria
Prior art keywords
flumethasone
acetate
androstene
carboxyl
analog
Prior art date
Application number
AT02735607T
Other languages
English (en)
Inventor
Ivan Villax
Zita Mendes
Original Assignee
Hovione Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20086054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE460422(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hovione Ltd filed Critical Hovione Ltd
Application granted granted Critical
Publication of ATE460422T1 publication Critical patent/ATE460422T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Control Of Combustion (AREA)
  • Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
AT02735607T 2001-06-12 2002-06-11 Herstellung von flumethasone und dessen 17- carboxyl androsten analog ATE460422T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT102628A PT102628B (pt) 2001-06-12 2001-06-12 Novo processo de preparação de flumetasona e do seu análogo 17-carboxilo androsteno
PCT/GB2002/002644 WO2002100878A1 (en) 2001-06-12 2002-06-11 Preparation of flumethasone and its 17-carboxyl androsten analogue

Publications (1)

Publication Number Publication Date
ATE460422T1 true ATE460422T1 (de) 2010-03-15

Family

ID=20086054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735607T ATE460422T1 (de) 2001-06-12 2002-06-11 Herstellung von flumethasone und dessen 17- carboxyl androsten analog

Country Status (19)

Country Link
US (1) US6528666B1 (de)
EP (1) EP1395603B1 (de)
JP (1) JP4095018B2 (de)
CN (1) CN1244593C (de)
AT (1) ATE460422T1 (de)
AU (1) AU2002310616B2 (de)
CA (1) CA2450661C (de)
CY (1) CY1109960T1 (de)
DE (1) DE60235625D1 (de)
DK (1) DK1395603T3 (de)
ES (1) ES2338768T3 (de)
IL (2) IL159343A0 (de)
NO (1) NO326153B1 (de)
NZ (1) NZ530536A (de)
PL (1) PL206731B1 (de)
PT (1) PT102628B (de)
RU (1) RU2260596C1 (de)
WO (1) WO2002100878A1 (de)
ZA (1) ZA200309656B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7098328B2 (en) * 2001-11-29 2006-08-29 Taro Pharmaceutical Industries Limited Method for the preparation of 6α-fluoro corticosteroids
ATE318274T1 (de) * 2002-12-09 2006-03-15 Sicor Inc Prozess zur herstellung von 6 alpa-fluorierten pregnanen
EP1526139A1 (de) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. Verfahren zur Herstellung von hochreinen Androstan-17-beta-carbonsäuren und Androstan-17-beta-fluoromethyl-thiocarbonsäureestern
CN100429221C (zh) * 2005-10-31 2008-10-29 浙江仙琚制药股份有限公司 皮质激素的合成方法
CN101759761B (zh) * 2008-11-28 2012-08-08 天津金耀集团有限公司 含有6α-F的甾体化合物的制备方法
WO2010079594A1 (ja) 2009-01-07 2010-07-15 三菱化学株式会社 ステロール側鎖切断酵素蛋白質およびその利用
CN101942002A (zh) * 2010-09-24 2011-01-12 岳阳环宇药业有限公司 一种甾体21位酯化物的精制工艺
ITMI20122200A1 (it) * 2012-12-20 2014-06-21 Trifarma Spa Processo per la preparazione di 6-alfa-fluoro pregnani
RU2532902C1 (ru) * 2013-07-12 2014-11-20 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) Способ получения 11бета, 17альфа, 21-тригидрокси-16альфа-метил-9альфа-фторпрегна-1,4-диен-3,20-диона (дексаметазона) из фитостерина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499016A (en) 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
US3636010A (en) 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4188322A (en) * 1978-04-28 1980-02-12 Blasinachim S.P.A. Process for the preparation of 6-halo-pregnanes
FR2701262B1 (fr) 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
IT1319663B1 (it) * 2000-11-17 2003-10-23 Farmabios Srl Processo per la preparazione di fluoro-steroidi.

Also Published As

Publication number Publication date
NO20035517D0 (no) 2003-12-11
NZ530536A (en) 2005-05-27
EP1395603A1 (de) 2004-03-10
DK1395603T3 (da) 2010-05-10
CY1109960T1 (el) 2014-09-10
IL159343A0 (en) 2004-06-01
RU2260596C1 (ru) 2005-09-20
IL159343A (en) 2010-11-30
PL206731B1 (pl) 2010-09-30
EP1395603B1 (de) 2010-03-10
CA2450661A1 (en) 2002-12-19
JP4095018B2 (ja) 2008-06-04
US6528666B1 (en) 2003-03-04
JP2004534795A (ja) 2004-11-18
CN1531544A (zh) 2004-09-22
CN1244593C (zh) 2006-03-08
PT102628A (pt) 2002-12-31
RU2004100309A (ru) 2005-07-10
AU2002310616B2 (en) 2007-08-30
PL367843A1 (en) 2005-03-07
CA2450661C (en) 2008-01-08
NO326153B1 (no) 2008-10-06
AU2002310616A2 (en) 2002-12-23
PT102628B (pt) 2010-09-09
ES2338768T3 (es) 2010-05-12
WO2002100878A1 (en) 2002-12-19
ZA200309656B (en) 2004-06-22
DE60235625D1 (de) 2010-04-22

Similar Documents

Publication Publication Date Title
CY1109960T1 (el) Παρασκευη φλουμεθαζονης και του αναλογου αυτης17-καρβοξυλο-ανδροστενιου
NZ610068A (en) Compositions comprising povidone-iodine
ES543499A0 (es) Un procedimiento para la preparacion de 16,17-acetales de derivados de pregnano
HK1082682A1 (en) Pharmaceutical composition
TW200504078A (en) Therapeutically active compounds and their use
DE602004018735D1 (de) Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität
HUP0000397A2 (hu) Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására
DE50206912D1 (de) Verfahren zur kontinuierlichen herstellung und beschichtung von selbstklebemassen auf basis von sbc mit mindestens einem pharmazeutischen wirkstoff
HUP0203295A2 (hu) Emphysema kezelése RAR-szelektív retinoid agonistákat tartalmazó gyógyszerkészítmények felhasználásával
ATE289318T1 (de) 17alfa, 21-dihydroxypregnene esters als antiandrogene wirkstoffe
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
NO20023276L (no) Fremgangsmåter fremstilling av betulinsyre
RS83104A (en) Process to prepare eplerenone
ECSP034470A (es) 6.alfa.,9.alfa-difluor-17.alfa.- (2-furanilcarboxilo) oxy-11.beta.-hidroxi-16.alfa.-metil-3-oxo-androst-1,4,-diene-17-acido carbotiotico s-fluormetil ester como un agente anti-inflamatorio
AU2003278434A1 (en) Cardiovascular protection using anti-aldosteronic progestins
NO20031964L (no) Fremgangsmåte for fremstilling av 16,17- [(cykloheksylmetylen)bis(oksy)]-11,21-dihydroksy-pregna-1,4-dien-3,20-dion eller dets 21-isobutyratved transketalisering
EP1194109A4 (de) Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung
DE602008006244D1 (de) Amorphe Form von (11beta,16alpha)-9-Fluoro-11-hydroxy-16,17-Ä(1-methylethyliden)bis(oxy)Ü-21-ÄÄ4- Ä(nitrooxy)methylÜbenzoylÜoxyÜ-pregna-1,4-dien-3,20-dion
SI1385527T1 (sl) Uporaba derivatov 2-alfa-ciano-4-alfa, 5-alfa-epoksiandrostan-17-beta-ol-3-ona za znižanje ravni serumskega kortizola in za zdravljenje s tem povezanih kliničnih stanj
Henley et al. EFFECT OF IONIZING RADIATION ON AQUEOUS ETHYLENE OXYGEN SOLUTIONS
WO2004033478A3 (en) Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
NO20054636L (no) Fremgangsmate for fremstilling av steroidale karbotiosyrederivater og -intermediater
Moriwaki et al. Treatment of Subglottic Stenosis
AR036567A1 (es) Transacetalizacion estereoselectiva del acetonido esteroidal en el c-22
GB1367928A (en) Halogenopregnadiene and process for its manufacture

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1395603

Country of ref document: EP